Citations

Mayo Clinic

Showing 10 of 108602 citations.

Perioperative Management of Female Hormone Medications
Seim, Lynsey A. , Irizarry-Alvarado, Joan M., Seim, Lynsey

Current Clinical Pharmacology | September 28, 2017 | Volume: 12 | Issue: 3 | Pages: 188-193

10.2174/1574884712666170927115947 | PMID 28969534 Get It

Anti-cytosolic 5′-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseases
Liewluck, Teerin , Liewluck, T

Neurology | September 28, 2017 | Volume: 89 | Issue: 19 | Pages: 2017-2018

10.1212/wnl.0000000000004610 | PMID 28954884 Get It

Optimizing Test Utilization in the Clinical Microbiology Laboratory: Tools and Opportunities
Pritt, Bobbi S. , Pritt, Bobbi S

Journal of Clinical Microbiology | September 28, 2017 | Volume: 55 | Issue: 12 | Pages: 3321-3323

10.1128/jcm.01332-17 | PMID 28954899 Get It

ABSTRACT Optimal laboratory test utilization is important for providing high-quality clinical care and efficiently using limited health care resources. While microbiologists have long been advocates for appropriate laboratory test utilization, the widespread availability of electronic medical records capable of supporting clinician order entry and of clinical decision support tools (CDSTs) has provided expanded opportunities for implementing effective, automated test stewardship protocols. D. Nikolic et al. (J. Clin. Microbiol. 55:3350–3354, 2017, https://doi.org/10.1128/JCM.01052-17 ) describe the results of implementing a CDST at their institution to curtail stool microbiology testing for patients hospitalized for more than 3 days. Their intervention significantly decreased unnecessary test orders and saved their laboratory over $8,000 in reagent and labor costs during an 11-month postintervention period. That report provides an excellent example of how clinical microbiologists can use electronic tools to optimize laboratory test utilization in their health care system.
Door-to-Needle Time in Acute Stroke Treatment and the “July Effect”
Carpani, Federico , Hawkes, Maximiliano A. , Farez, Mauricio , Ameriso, Sebastian Francisco

The Neurohospitalist | September 28, 2017 | Volume: 8 | Issue: 1 | Pages: 24-28

10.1177/1941874417733108 | PMID 29276559 Get It

Intravenous thrombolysis improves outcomes in acute ischemic stroke in a time-dependent fashion. As in teaching hospitals, clinical outcomes may worsen due to the arrival of new inexperienced house staff early in the academic year (July effect, JE), we evaluated the impact of the “JE” on the door-to-needle time for intravenous thrombolysis and other stroke outcomes. In this retrospective cohort study, we assessed all acute ischemic strokes treated with intravenous thrombolysis between July 2003 and June 2016. Among 101 patients, there was no detrimental July effect on the door-to-needle time, rate of thrombolysis within 60 minutes of arrival, thrombolysis of stroke mimics, post-thrombolysis intracranial hemorrhages, National Institutes of Health Stroke Scale, and modified Rankin Scale outcomes.
Seven tips for developing and maintaining a high performance sports medicine team
Gabbett, Tim J. , Kearney, Simon, Bisson, Leslie J. , Sikka, Robby , Winder, Nathan, Sedgwick, Craig, Hollis, Ed , Bettle, Jeremy M., Collins, Joe T.

British Journal of Sports Medicine | September 27, 2017 | Volume: 52 | Issue: 10 | Pages: 626-627

10.1136/bjsports-2017-098426 | PMID 28954792 Get It

CRISPR Genome-Wide Screening Identifies Dependence on the Proteasome Subunit PSMC6 for Bortezomib Sensitivity in Multiple Myeloma
Shi, Chang-Xin, Zhu, Yuan Xiao , Bruins, Laura A., Jedlowski, Patrick , Votruba, Patrick G., Luo, Moulun , Ahmann, Jonathan M., Braggio, Esteban , Stewart, A. Keith, Stewart, Robert A, Ahmann, Jonathan, Braggio, Esteban , Kortüm, K. Martin , Stewart, Robert

Molecular Cancer Therapeutics | September 27, 2017 | Volume: 16 | Issue: 12 | Pages: 2862-2870

10.1158/1535-7163.mct-17-0130 | PMID 28958990 Get It

Abstract Bortezomib is highly effective in the treatment of multiple myeloma; however, emergent drug resistance is common. Consequently, we employed CRISPR targeting 19,052 human genes to identify unbiased targets that contribute to bortezomib resistance. Specifically, we engineered an RPMI8226 multiple myeloma cell line to express Cas9 infected by lentiviral vector CRISPR library and cultured derived cells in doses of bortezomib lethal to parental cells. Sequencing was performed on surviving cells to identify inactivated genes responsible for drug resistance. From two independent whole-genome screens, we selected 31 candidate genes and constructed a second CRISPR sgRNA library, specifically targeting each of these 31 genes with four sgRNAs. After secondary screening for bortezomib resistance, the top 20 “resistance” genes were selected for individual validation. Of these 20 targets, the proteasome regulatory subunit PSMC6 was the only gene validated to reproducibly confer bortezomib resistance. We confirmed that inhibition of chymotrypsin-like proteasome activity by bortezomib was significantly reduced in cells lacking PSMC6. We individually investigated other members of the PSMC group (PSMC1 to 5) and found that deficiency in each of those subunits also imparts bortezomib resistance. We found 36 mutations in 19S proteasome subunits out of 895 patients in the IA10 release of the CoMMpass study (https://themmrf.org). Our findings demonstrate that the PSMC6 subunit is the most prominent target required for bortezomib sensitivity in multiple myeloma cells and should be examined in drug-refractory populations. Mol Cancer Ther; 16(12); 2862–70. ©2017 AACR.
An Efficient Test for Gene-Environment Interaction in Generalized Linear Mixed Models with Family Data
Mazo-Lopera, Mauricio Alejandro , Coombes, Brandon J. , Mazo Lopera, Mauricio A , de Andrade, Mariza, Andrade, Mariza de , Coombes, Brandon J

International Journal of Environmental Research and Public Health | September 27, 2017 | Volume: 14 | Issue: 10 | Pages: 1134

10.3390/ijerph14101134 | PMID 28953253 Get It

Gene-environment (GE) interaction has important implications in the etiology of complex diseases that are caused by a combination of genetic factors and environment variables. Several authors have developed GE analysis in the context of independent subjects or longitudinal data using a gene-set. In this paper, we propose to analyze GE interaction for discrete and continuous phenotypes in family studies by incorporating the relatedness among the relatives for each family into a generalized linear mixed model (GLMM) and by using a gene-based variance component test. In addition, we deal with collinearity problems arising from linkage disequilibrium among single nucleotide polymorphisms (SNPs) by considering their coefficients as random effects under the null model estimation. We show that the best linear unbiased predictor (BLUP) of such random effects in the GLMM is equivalent to the ridge regression estimator. This equivalence provides a simple method to estimate the ridge penalty parameter in comparison to other computationally-demanding estimation approaches based on cross-validation schemes. We evaluated the proposed test using simulation studies and applied it to real data from the Baependi Heart Study consisting of 76 families. Using our approach, we identified an interaction between BMI and the Peroxisome Proliferator Activated Receptor Gamma (PPARG) gene associated with diabetes.
Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia
Kahn, Allon , Al-Qaisi, Mohanad, Kommineni, Vishnu, Callaway, Jonathan K., Boroff, Erika, Burdick, George E., Lam‐Himlin, Dora , Temkit, M’hamed , Vela, Marcelo F. , Ramirez, Francisco C. , Kahn, Allon

Diseases of the Esophagus | September 27, 2017 | Volume: 31 | Issue: 4 | Pages: No page available

10.1093/dote/dox120 | PMID 29036431 Get It

Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL)
Tandon, Nidhi , Sidana, Surbhi , Lacy, Martha Q. , Dingli, David , Fonder, Amie , Hayman, Suzanne R. , Hwa, Yi L. , Hobbs, Miriam, Kapoor, Prashant , Gonsalves, Wilson I. , Leung, Nelson , Go, Ronald S. , Lust, John A., Russell, Stephen J. , Kyle, Robert A. , Kumar, Shaji , Buadi, Francis K. , Fonder, Amie L, Hwa, Yi Lisa, Gonsalves, Wilson , Leung, Nelson , Go, Ronald S , Russell, Stephen J , Sidana, Surbhi , Dingli, David , Dispenzieri, Angela , Gertz, Morie A. , Rajkumar, S. Vincent

American Journal of Hematology | September 27, 2017 | Volume: 93 | Issue: 1 | Pages: 17-22

10.1002/ajh.24919 | PMID 28960427 Get It

AbstractAchievement of a normal FLC ratio (FLCr) following treatment indicates hematologic response and suggests better outcomes in light chain amyloidosis (AL). We examined if elevated involved free light chain (hiFLC) impacts outcomes in patients achieving normal FLCr. We retrospectively analyzed 345 AL patients who were diagnosed within a 10‐year period (2006‐2015) and had 2 consecutive normal FLCr values after 1st line treatment. Among these, patients with hiFLC at 1st reading of normal FLCr (hiFLC1; n = 166; 48.1%) were compared to those who did not (n = 179; 51.9%). Patients with AL who have hiFLC1 after initial therapy had higher rates of multi‐organ involvement (63.3 vs 46.4%; P = .002) and patients in advanced Mayo stage (42.9 vs 32.2%; P = .04) at diagnosis. The median progression free survival [PFS; 38.2 (95%CI; 26.4, 55.4) vs 67.1 (95%CI; 55.8, 88) months; P = .0002] and overall survival [OS; 94.4 (95%CI; 78, 107.1) vs not reached (NR, 95%CI; 116.1, NR) months; P < .0001] were lower in those who had hiFLC1. A more stringent comparison for patients with 2 consecutive hiFLC (hIFLC2; n = 111; 32.2%) versus not (n = 2234; 67.8%) showed consistent results [PFS; 27.1 (95%CI; 23, 53.8) vs 63.3 (95%CI; 55.4, 77) months; P < .0001 and OS; 78 (95% CI; 54.6, 98.8) vs NR (95%CI; NR, NR); P < .0001]. This poor prognostic impact of hiFLC on survival was independent of serum creatinine, Mayo stage, negative immunofixation status and inclusion of transplant in initial therapy on multivariate analysis. Hence, persistent elevation of iFLC predicts poor prognosis even among patients achieving normal ratio after initial therapy in AL.
A baseline drift detrending technique for fast scan cyclic voltammetry
DeWaele, Mark, Park, Cheonho , Kang, Yu Min , Shin, Hojin , Bennet, Kevin E. , Lee, Kendall H. , Jang, Dong Pyo , Oh, Yoonbae , Blaha, Charles D. , Kim, In Young

The Analyst | September 27, 2017 | Volume: 142 | Issue: 22 | Pages: 4317-4321

10.1039/c7an01465a | PMID 29063091 Get It

A simple, and yet robust, high pass filter is designed to remove non-linear background drift in fast scan cyclic voltammetry.